0N6Z.L - Biotest Aktiengesellschaft

LSE - LSE Delayed price. Currency in EUR
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.29
52-week change 3N/A
S&P500 52-week change 36.21%
52-week high 30.00
52-week low 30.00
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 539.57M
Implied shares outstanding 6N/A
Float 819.98M
% held by insiders 189.88%
% held by institutions 10.52%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023

Profitability

Profit margin -9.12%
Operating margin (ttm)-4.70%

Management effectiveness

Return on assets (ttm)-1.32%
Return on equity (ttm)-13.00%

Income statement

Revenue (ttm)517.4M
Revenue per share (ttm)13.01
Quarterly revenue growth (yoy)1.10%
Gross profit (ttm)N/A
EBITDA 7.42M
Net income avi to common (ttm)-47.2M
Diluted EPS (ttm)-1.37
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)68M
Total cash per share (mrq)1.77
Total debt (mrq)650.9M
Total debt/equity (mrq)185.39
Current ratio (mrq)4.61
Book value per share (mrq)9.12

Cash flow statement

Operating cash flow (ttm)-97.8M
Levered free cash flow (ttm)-125.05M